These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12906208)

  • 1. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
    Lindsay PE; Van Dyk J; Battista JJ
    Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
    De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
    Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose uncertainty due to computed tomography (CT) slice thickness in CT-based high dose rate brachytherapy of the prostate cancer.
    Kim Y; Hsu IC; Lessard E; Pouliot J; Vujic J
    Med Phys; 2004 Sep; 31(9):2543-8. PubMed ID: 15487736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
    Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
    Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
    Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
    Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem.
    Su Y; Davis BJ; Herman MG; Robb RA
    Med Phys; 2004 May; 31(5):1277-87. PubMed ID: 15191320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
    Meigooni AS; Luerman CM; Sowards KT
    Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
    Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
    Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality.
    Major T; Fodor J; Takácsi-Nagy Z; Agoston P; Polgár C
    Strahlenther Onkol; 2005 Feb; 181(2):89-96. PubMed ID: 15702297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
    Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
    Li XA; Wang JZ; Stewart RD; DiBiase SJ
    Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.